Anthropic Develops Drug Research AI Tool, Plans Clinical Studies for Neglected Diseases
Anthropic is expanding beyond its core language model business into pharmaceutical research with a dedicated drug discovery tool. The company intends to use this AI system to identify potential treatments for overlooked diseases—conditions that often lack commercial investment due to smaller patient populations or lower profitability. This move represents a notable shift for Anthropic, as the company would conduct actual clinical studies rather than simply providing technology to external partners. The initiative reflects a broader trend of AI companies exploring healthcare applications, though the specific diseases targeted and the timeline for bringing candidates through development remain to be detailed.